QuantHealth is an Israeli biotech and pharmaceutical research company headquartered in Tel Aviv-Yafo. It works to reduce the risk involved with drug development by conducting patient-centric research and has secured a strategic investment from Accenture Ventures.
Subscribe to see QuantHealth’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
QuantHealth is a healthtech company headquartered in Israel. It has raised at least $60M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $45M in August 2026. Xcout tracks 7 named people at QuantHealth, including Adam Goldberger (Chief Financial Officer). Xcout recorded 8 job postings from QuantHealth in the last 90 days.
1 more named person on record for QuantHealth, with roles, board committees and tenure — see the full roster →
At least $60M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $45M | 10 named | |
| Series A | $15M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 8 job postings from QuantHealth in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see QuantHealth's hiring signals →
A few of QuantHealth's closest competitors — see the full list of competitors and alternatives →
Nova In Silico provides a collaborative clinical trial simulation platform called jinkō, which uses disease models and virtual patient populations to predict clinical outcomes. The company serves pharmaceutical and biotech organizations by helping them optimize trial design, reduce risks to human subjects, and accelerate drug development from discovery to market access.
Novadiscovery provides a collaborative clinical trial simulation platform called jinkō that uses disease models and digital patients to predict clinical outcomes. The company serves pharmaceutical and life sciences organizations by optimizing trial design, reducing risks to human subjects, and accelerating drug development from discovery to market access.
InSilicoTrials is a healthcare technology company headquartered in Trieste, Italy, specializing in computational modeling and AI. The platform helps pharmaceutical and device developers run clinical trial simulations to accelerate research and strengthen study design.
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
Unlearn.AI is a research services and technology company headquartered in San Francisco, California. The company transforms clinical development by applying AI-powered solutions to make clinical trials smarter and help biopharma companies reach milestones faster.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.